Cargando…
Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi
Currently there is no licensed vaccine against the human pathogen Streptococcus pyogenes. The highly conserved IL-8 cleaving S. pyogenes cell envelope proteinase SpyCEP is surface expressed and is a potential vaccine candidate. A recombinant N-terminal part of SpyCEP (CEP) was expressed and purified...
Autores principales: | Turner, Claire E., Kurupati, Prathiba, Wiles, Siouxsie, Edwards, Robert J., Sriskandan, Shiranee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759039/ https://www.ncbi.nlm.nih.gov/pubmed/19563892 http://dx.doi.org/10.1016/j.vaccine.2009.06.042 |
Ejemplares similares
-
Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract
por: Kurupati, Prathiba, et al.
Publicado: (2010) -
Structure–activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal
por: Pearson, Max, et al.
Publicado: (2023) -
Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes
por: McKenna, Sophie, et al.
Publicado: (2020) -
A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP
por: Goldblatt, Jennifer, et al.
Publicado: (2019) -
Non-Invasive Monitoring of Streptococcus pyogenes Vaccine Efficacy Using Biophotonic Imaging
por: Alam, Faraz M., et al.
Publicado: (2013)